Antihypertensive Treatment in the Postpartum Care of Preeclampsia: A Hemodynamic-Based Approach

Abstract

Objective

Labetalol and nifedipine are first-line antihypertensives for hypertensive disorders of pregnancy. However, there is limited research comparing their effectiveness based on hemodynamic profiles seen in preeclampsia, such as high cardiac output (CO) and high systemic vascular resistance (SVR). This study assesses whether concordance of antihypertensive treatment with the hemodynamic status on echocardiogram reduces time to achieve target postpartum blood pressure (BP) before discharge.

Study Design

This retrospective cohort study included patients with preeclampsia with severe features who received a postpartum echocardiography, excluding patients with cardiac etiology. Antihypertensive choices were provider-dependent. The CO and SVR were calculated retrospectively from the echocardiogram in collaboration with cardiology. Concordance was defined as patients with high CO (>6 L/min) started on labetalol and high SVR (>1,200 dynes·sec·cm⁵) started on nifedipine; opposite pairings were discordant. The primary outcome was time to achieve target BP, defined as the period from the start of antihypertensive therapy to when no titration was needed to sustain BPs of less than 140/90 mm Hg. Chi-square and Fisher's tests were used for categorical variables, and Mann–Whitney U test for continuous variables.

Results

Of 298 patients, 155 (52%) received concordant therapy and 143 (48%) discordant. Of the cohort, 229 (76.8%) had high SVR and 69 (23.2%) had high CO. Median time to target BP was not significantly different (concordant: 32 hours [interquartile range, IQR: 0–61], discordant: 41 hours [IQR: 4–75], p = 0.13). The concordant group needed fewer titrations to achieve target BP (1 [IQR: 0–2] vs. 2 [IQR: 1–3]; p = 0.008) and were less likely to be discharged home on multiple antihypertensive medications compared with the discordant group (28.9 vs. 42.7%, p = 0.014). Maternal demographics were similar between groups.

Conclusion

While time to target BP did not differ, concordance of antihypertensive therapy to postpartum hemodynamics in patients with severe preeclampsia reduced medication adjustments and increased the likelihood of discharge on a single-agent regimen.

Key Points

• Echocardiography can be used to assess maternal hemodynamics.

• Aligning BP meds to hemodynamics cuts the need for a second agent.

• Aligning BP meds to hemodynamics reduces dose adjustments.

Keywords

hemodynamic profiles - preeclampsia - concordant therapy - hypertension - echocardiography

Publikationsverlauf

Eingereicht: 20. August 2025

Angenommen: 23. September 2025

Artikel online veröffentlicht:
08. Oktober 2025

• References

• 1 Ford ND, Cox S, Ko JY. et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization—United States, 2017–2019. MMWR Morb Mortal Wkly Rep 2022; 71 (17) 585-591
• 2 Griffin MM, Black M, Deeb J, Penfield CA, Hoskins IA. Postpartum readmissions for hypertensive disorders in pregnancy during the COVID-19 pandemic. AJOG Glob Rep 2022; 2 (04) 100108
• 3 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 203: Chronic hypertension in pregnancy. Obstet Gynecol 2019; 133: e26-e50
• 4 McLaughlin K, Scholten RR, Kingdom JC, Floras JS, Parker JD. Should maternal hemodynamics guide antihypertensive therapy in preeclampsia?. Hypertension 2018; 71 (04) 550-556
• 5 Lachaud AE, Hirshberg A, Levine LD. Antihypertensive medication to prevent postpartum hypertension-related readmissions: Necessary but not sufficient. Am J Obstet Gynecol 2024; 231 (04) 375-376
• 6 Easterling TR, Watts DH, Schmucker BC, Benedetti TJ. Measurement of cardiac output during pregnancy: Validation of Doppler technique and clinical observations in preeclampsia. Obstet Gynecol 1987; 69 (06) 845-850
• 7 McLaughlin K, Snelgrove JW, Sienas LE, Easterling TR, Kingdom JC, Albright CM. Phenotype-directed management of hypertension in pregnancy. J Am Heart Assoc 2022; 11 (07) e023694
• 8 Lees C, Ferrazzi E. Relevance of haemodynamics in treating pre-eclampsia. Curr Hypertens Rep 2017; 19 (09) 76
• 9 di Pasquo E, Giannubilo SR, Valentini B. et al. The “Preeclampsia and Hypertension Target Treatment” study: A multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings. Am J Obstet Gynecol MFM 2024; 6 (05) 101368
• 10 Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014; 130 (12) 1003-1008
• 11 Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am J Obstet Gynecol 2022; 226 (2S): S988-S1005
• 12 Easterling TR, Benedetti TJ, Schmucker BC, Carlson KL. Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring. Am J Perinatol 1989; 6 (01) 86-89
• 13 Stott D, Papastefanou I, Paraschiv D, Clark K, Kametas NA. Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension. Ultrasound Obstet Gynecol 2017; 49 (01) 95-103
• 14 Smith RD, Levy P, Ferrario CM. Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension 2006; 47 (04) 771-777
• 15 Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52 (05) 873-880
• 16 Melchiorre K, Sutherland G, Sharma R, Nanni M, Thilaganathan B. Mid-gestational maternal cardiovascular profile in preterm and term pre-eclampsia: A prospective study. BJOG 2013; 120 (04) 496-504
• 17 Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: Defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol 2022; 226 (2S): S1211-S1221
• 18 Kantorowska A, Corbo AM, Akerman MB. et al. The value of maternal echocardiography after delivery in patients with severe preeclampsia. Am J Obstet Gynecol 2024; 231 (02) e67-e69
• 19 van der Zande JA, Rijs K, Shamshirsaz AA. et al. The role of point-of-care ultrasound (POCUS) in maternal medicine. Best Pract Res Clin Obstet Gynaecol 2025; 100: 102599
• 20 Algodi M, Wolfe DS, Taub CC. The utility of maternal point of care ultrasound on labor and delivery wards. J Cardiovasc Dev Dis 2022; 9 (01) 29